Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 692

Results For "IND"

7102 News Found

Cadila Healthcare completes sale of animal healthcare business
News | July 16, 2021

Cadila Healthcare completes sale of animal healthcare business

The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.


Caplin gets USFDA approval for Sumatriptan
News | July 15, 2021

Caplin gets USFDA approval for Sumatriptan

Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache


Brooks announces new investments to build an integrated carbapenem business
News | July 15, 2021

Brooks announces new investments to build an integrated carbapenem business

SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL


Vikas Lifecare acquires 22.04% stake in Advik Laboratories
News | July 15, 2021

Vikas Lifecare acquires 22.04% stake in Advik Laboratories

Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company


Sequent Scientific announces EUGMP approval for tablets
News | July 15, 2021

Sequent Scientific announces EUGMP approval for tablets

The company has already embarked upon significant expansion in Turkey


Borealis appoints IMCD as healthcare portfolio distributor
Supply Chain | July 13, 2021

Borealis appoints IMCD as healthcare portfolio distributor

The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices


Unichem receives tentative approval for ANDA of Sitagliptin tablets
News | July 11, 2021

Unichem receives tentative approval for ANDA of Sitagliptin tablets

Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus


Alembic announces USFDA approval for Desipramine Hydrochloride Tablets
News | July 09, 2021

Alembic announces USFDA approval for Desipramine Hydrochloride Tablets

The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA


RDIF and Morepen announce production of test batch of Sputnik V
News | July 08, 2021

RDIF and Morepen announce production of test batch of Sputnik V

The first batch will be shipped to the Gamaleya Center for the quality control


Panacea Biotec gets license to produce Sputnik V vaccine at Baddi
News | July 05, 2021

Panacea Biotec gets license to produce Sputnik V vaccine at Baddi

The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India